Clinical Trial Update: A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating maintenance therapy with venetoclax and azacitidine in adults with acute myeloid leukemia in first remission after conventional chemoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VIDAZA (AZACITIDINE)
• Venclexta (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Acute Myeloid Leukemia (AML) | Phase 3 | Status: COMPLETED | Results posted: 2025-08-20